A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England. About 50 people a year with the inherited blood disorder are likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback